Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Shares Issued (2016 - 2024)

Medifast (MED) has disclosed Shares Issued for 9 consecutive years, with $36000.0 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Shares Issued fell 65.71% year-over-year to $36000.0, compared with a TTM value of $36000.0 through Dec 2024, down 80.85%, and an annual FY2024 reading of $36000.0, down 80.85% over the prior year.
  • Shares Issued was $36000.0 for Q1 2024 at Medifast, down from $83000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $500000.0 in Q1 2021 and bottomed at $36000.0 in Q1 2024.
  • Average Shares Issued over 4 years is $166875.0, with a median of $116500.0 recorded in 2020.
  • The sharpest move saw Shares Issued fell 12.1% in 2021, then plummeted 65.71% in 2024.
  • Year by year, Shares Issued stood at $176000.0 in 2020, then plummeted by 38.07% to $109000.0 in 2021, then fell by 23.85% to $83000.0 in 2023, then tumbled by 56.63% to $36000.0 in 2024.
  • Business Quant data shows Shares Issued for MED at $36000.0 in Q1 2024, $83000.0 in Q4 2023, and $105000.0 in Q1 2023.